as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.90%
Downside
0.95%
Upside
52 Week's Low
52 Week's High
23.03%
Downside
33.74%
Upside
Check Biogen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$21.0B
EPS (TTM)
15.7256
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.08%
PE Ratio (TTM)
13.68
Industry PE ratio
19.200384615384614
PEG Ratio
6.2424
EBITDA
3.2B
Revenue (TTM)
10.0B
Profit Margin
15.31%
Return On Equity TTM
9.13%
Track how Biogen Inc. P/E has moved over time to understand its valuation trends.
Biogen Inc. in the last 5 years
Lowest (7.86x)
December 31, 2020
Today (13.68x)
October 18, 2025
Industry (19.20x)
October 18, 2025
Highest (18.33x)
June 30, 2023
Today’s Price to Earnings Ratio: 13.68x
Compare market cap, revenue, PE, and other key metrics of Biogen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $21.0B | -48.93% | 13.68 | 15.31% | |
BUY | $719.7B | 449.43% | 52.37 | 25.91% | |
BUY | $400.8B | 166.11% | 107.52 | 6.45% | |
BUY | $462.7B | 30.47% | 18.54 | 27.26% | |
BUY | $253.6B | 53.11% | 14.46 | 35.61% |
The Biogen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biogen Inc. investment value today
Current value as on today
₹79,973
Returns
Returns from Biogen Inc. Stock
Dollar Returns*
₹4,794 (+4.79%)
Based on 42 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 42 analysts, 71.43% of analysts recommend a 'BUY' rating for Biogen Inc.. Average target price of $172.34
Get share price movements and forecasts by analysts on Biogen Inc..
What analysts predicted
17.05%UPSIDE
Target Price
$172.34
Current Price
$142.96
Analyzed by
42 Analysts
Target
$172.34
Biogen Inc. target price $172.34, a slight upside of 17.05% compared to current price of $142.96. According to 42 analysts rating.
Search interest for Biogen Inc. Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 06 October
Tue, 02:06 AM
-Eisai and Biogen launch Leqembi Companion program to support patients during treatment journey.
Tue, 02:32 AM
-Eisai and Biogen announce availability of lecanemab-irmb subcutaneous injection for Alzheimer's treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 2.43B → 2.64B (in $), with an average increase of 8.1% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 240.5M → 634.8M (in $), with an average increase of 62.1% per quarter
Against Peers
In the last 1 year, Abbvie Inc has given 21.6% return, outperforming this stock by 46.4%
Against Peers
In the last 3 years, Eli Lilly And Company has given 58.8% return, outperforming this stock by 105.9%
Price Dip
In the last 7 days, BIIB stock has moved down by -2.4%
Organisation | Biogen Inc. |
Headquarters | 225 Binney Street, Cambridge, MA, United States, 02142 |
Industry | Health Technology |
CEO | Mr. Christopher A. Viehbacher |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Christopher A. Viehbacher | President, CEO & Director |
Ms. Nicole Murphy | Executive VP and Head of Pharmaceutical Operations & Technology |
Ms. Susan H. Alexander Esq. | Executive VP & Chief Legal Officer |
Dr. Priya Singhal M.D., M.P.H. | Executive VP & Head of Development |
Ms. Robin C. Kramer | Executive VP & CFO |
Mr. Sean Godbout | Chief Accounting Officer & Global Corporate Controller |
Biogen Inc. share price today is $142.96 as on at the close of the market. Biogen Inc. share today touched a day high of $144.32 and a low of $141.67.
Biogen Inc. share touched a 52 week high of $191.19 on and a 52 week low of $110.04 on . Biogen Inc. stock price today i.e. is closed at $142.96,which is 25.23% down from its 52 week high and 29.92% up from its 52 week low.
Biogen Inc. market capitalisation is $0.02T as on .
Indian investors can start investing in Biogen Inc. (BIIB) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Biogen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biogen Inc. share’s latest price of $142.96 as on October 18, 2025 at 1:29 am IST, you will get 0.0699 shares of Biogen Inc.. Learn more about
fractional shares .
Biogen Inc. stock has given -48.93% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?